SCHEMBL4683600

SCHEMBL4683600

CC1(C)CCc2nc(-c3nc(-c4ccccc4)c(F)n3-c3cccnc3)ccc2C1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 2/20 0.40
GRM1 Q13255 2/20 0.38
ALOX12 P18054 1/20 0.36
MDM2 Q00987 1/20 0.35
AKT1 P31749 1/20 0.33
CYP11B2 P19099 2/20 0.32
GSR P00390 1/20 0.32
CYP11B1 P15538 1/20 0.32
CYP1A2 P05177 1/20 0.32
POLB P06746 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
RAB9A P51151 2/20 0.32
G6PD P11413 1/20 0.32
MAPT P10636 4/20 0.32
PARP10 Q53GL7 1/20 0.31
PARP11 Q9NR21 1/20 0.31
KDM4E B2RXH2 1/20 0.31
NPC1 O15118 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4680738 0.98 GRM5 (0.39) GRM5GRM1ALOX12MDM2AKT1
SCHEMBL4683064 0.95 GRM1 (0.39) GRM5GRM1ALOX12MDM2AKT1
SCHEMBL4679352 0.93 GRM5 (0.46) GRM5CYP2C19ALDH1A1
SCHEMBL6103711 0.86 GRM5 (0.41) GRM5MDM2CYP1A2CYP3A4CYP2C9
SCHEMBL4682564 0.82 GRM5 (0.37) GRM5MDM2AKT1CYP1A2CYP3A4
SCHEMBL6103251 0.81 GRM5 (0.46) GRM5AKT1CYP1A2CYP3A4CYP2C9
SCHEMBL13706965 0.78 GRM5 (0.49) GRM5GRM1CYP11B2CYP11B1CYP1A2
SCHEMBL15071808 0.77 CYP11B2 (0.36) GRM1AKT1CYP11B2CYP11B1MAPT
SCHEMBL4686026 0.76 USP8 (0.42) GRM5GRM1CYP11B2CYP11B1CYP1A2
SCHEMBL4684173 0.76 LMNA (0.42) GRM5MAPTKDM4EALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1943247-A1 TETRAHYDROQUINOLINONES AND THEIR USE AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS Merz Pharma GmbH & Co.KGaA (DE) 2008-07-16 EP claimed
WO-2007023245-A1 TETRAHYDROQUINOLINONES AND THEIR USE AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS MERZ PHARMA GMBH & CO. KGAA (DE) 2007-03-01 WO claimed
US-20060004001-A1 Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors MERZ PHARMA GMBH & CO., KGAA (DE) 2006-01-05 US claimed
EP-1943247-A1 TETRAHYDROQUINOLINONES AND THEIR USE AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS Merz Pharma GmbH & Co.KGaA (DE) 2008-07-16 EP disclosed
WO-2007023245-A1 TETRAHYDROQUINOLINONES AND THEIR USE AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS MERZ PHARMA GMBH & CO. KGAA (DE) 2007-03-01 WO disclosed
WO-2007023245-A1 TETRAHYDROQUINOLINONES AND THEIR USE AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS MERZ PHARMA GMBH & CO. KGAA (DE) 2007-03-01 WO disclosed
US-20060004001-A1 Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors MERZ PHARMA GMBH & CO., KGAA (DE) 2006-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060004001-A1 Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors GRM1, GRM5, GRM2 GRM5 2/4885GRM1 1/4885ALOX12 2695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.